Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Blai Dalmau"'
Autor:
Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241559 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0208112.].
Externí odkaz:
https://doaj.org/article/5129c8b9691749f092aaacf1085dfd61
Autor:
Lara Albert, Joaquím Profitós, Jordi Sánchez-Delgado, Ismael Capel, José Miguel González-Clemente, David Subías, Albert Cano, Eugenio Berlanga, Anna Espinal, Marta Hurtado, Rocío Pareja, Mercedes Rigla, Blai Dalmau, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Olga Giménez-Palop
Publikováno v:
International Journal of Endocrinology, Vol 2019 (2019)
Purpose. The prevalence of adrenal insufficiency (AI) in patients with decompensated liver cirrhosis is unknown. Because these patients have lower levels of cortisol-binding carrier proteins, their total serum cortisol (TSC) correlates poorly with fr
Externí odkaz:
https://doaj.org/article/e5b57baca2274f8c8bd0782e1d79261b
Autor:
Marta Gallach, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Jordi Sánchez-Delgado, Blai Dalmau, Montserrat Gil, Núria Rudi, Isabel Parra, Maria López, Angelina Dosal, Laura Moreno, Oliver Valero, Xavier Calvet
Publikováno v:
Annals of Hepatology, Vol 15, Iss 4, Pp 524-531 (2016)
Background. Despite the introduction of direct antiviral agents, pegylated interferon remains the mainstay of treatment for chronic hepatitis C. However, pegylated interferon is associated with a high rate of severe adverse events and decreased quali
Externí odkaz:
https://doaj.org/article/299c63d1b30e46519f8415bd16435058
Autor:
Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208112 (2018)
BACKGROUND AND AIM:Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side effects. Although pivotal studies suggested that DAA were safe in patients with psychiatric diseases who could not be treated with previous antiviral t
Externí odkaz:
https://doaj.org/article/91db3feabd944fe8b221f4d7fdf932bc
Autor:
Juan José Urquijo, Moisés Diago, M.D., Jaume Boadas, Ramón Planas, Ricard Solá, Juan Angel del Olmo, Javier Crespo, José Carlos Erdozaín, María Dolores Antón, Carlos Arocena, Dolores Suarez, Josep Giné, Josep M Barrera, Javier Gracia-Samaniego, Ricardo Perez, Blai Dalmau, Miguel Montoro
Publikováno v:
Annals of Hepatology, Vol 12, Iss 1, Pp 30-35 (2013)
The hepatitis C virus (HCV) genotype is an important predictive outcome parameter for pegylated interferon plus ribavirin therapy. Most published therapeutic trials to date have enrolled mainly patients with HCV genotypes 1, 2 and 3. Limited studies
Externí odkaz:
https://doaj.org/article/98dcbc9f1b3644c49714f9f6fc02e4a9
Autor:
Mireia Miquel, Julia Sopeña, Mercedes Vergara, Montserrat Gil, Meritxell Casas, Jorge Sánchez-Delgado, Jordi Puig, Anna Alguersuari, Eva Criado, Blai Dalmau
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 104, Iss 5, Pp 242-247 (2012)
Background: hepatocellular carcinoma (HCC) is a very frequent tumor. Screening for the disease is effective, but the prognostic factors are difficult to evaluate. Objectives: 1. To determine epidemiological data and the clinical course of HCC in our
Externí odkaz:
https://doaj.org/article/a3023994448042588a22143da1bb8144
Autor:
Luís Moreno, Jordi Sánchez-Delgado, Mercedes Vergara, Meritxell Casas, Mireia Miquel, Blai Dalmau
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 107, Iss 12, Pp 767-768 (2015)
Externí odkaz:
https://doaj.org/article/0d7a10dbb9184a68b6ad086f175d0c41
Autor:
Meritxell Casas, Mercedes Vergara, Enric Brullet, Félix Junquera, Eva Martínez-Bauer, Mireia Miquel, Jordi Sánchez-Delgado, Blai Dalmau, Rafael Campo, Xavier Calvet
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 3, Pp 166-171
RESUMEN Introducción: en la actualidad no existe una clasificación endoscópica totalmente aceptada para evaluar el grado de gastropatía de la hipertensión portal (GHP). Hay pocos estudios que evalúen la concordancia inter e intraobservador o el
Externí odkaz:
https://doaj.org/article/ad213a685d8f467297dc99f994b72d5b
Autor:
Luigi Melcarne, Julia Sopeña, Francisco-José Martínez-Cerezo, Mercedes Vergara, Mireia Miquel, Jordi Sánchez-Delgado, Blai Dalmau, Salvador Machlab, Dustin Portilla, Yonaisy González-Padrón, Mónica Real-Álvarez, Chantal Carpintero, Meritxell Casas
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 2, Pp 94-101
RESUMEN Introducción: la peritonitis bacteriana espontánea es una complicación infecciosa con impacto negativo sobre la supervivencia de los pacientes con cirrosis. Objetivo: analizar la supervivencia a corto y largo plazo después de un primer ep
Externí odkaz:
https://doaj.org/article/fb4b89a8e68c471caa8aef8969129915
Autor:
Mercedes Vergara, Oliver Valero, Jordi Sánchez-Delgado, Leticia Hernandez, Eduard Brunet, Mireia Miquel, Meritxell Casas, Blai Dalmau
Publikováno v:
Medicina Clínica (English Edition). 152:377-383
Background and objectives Primary biliary cholangitis (PBC) is an autoimmune disease that affects the small bile ducts. The only treatments currently approved in our country are ursodeoxycholic acid (UDCA) and obeticholic acid. Different indices eval